# Revised Two-Stage Model of Preeclampsia Based on Autophagic Dysfunction: A Comprehensive Review

**Authors:** Atsushi Furuta, Tomoko Shima, Takashi Nishigori, Kiyotaka Yamada, Haruka Nunomura, Mihoko Yoshida, Shina Sakaguchi, Takuya Majima, Akemi Yamaki-Ushijima, Kanto Shozu, Sayaka Tsuda, Shibin Cheng, Surendra Sharma, Akitoshi Nakashima

PMC · DOI: 10.3390/biom16030441 · Biomolecules · 2026-03-15

## TL;DR

This paper proposes a new model for preeclampsia based on autophagy dysfunction during early placenta development.

## Contribution

The paper introduces a revised two-stage model of preeclampsia centered on autophagy and trophoblast invasion into the myometrium.

## Key findings

- Autophagy dysfunction may lead to shallow trophoblast invasion and placental hypoxia.
- Impaired autophagy could contribute to preeclampsia through disrupted energy homeostasis and placental injury signals.
- Early risk stratification and treatment may be possible through autophagy markers and TFEB activation.

## Abstract

A revised two-stage model of preeclampsia is proposed, centering on an autophagy-dependent requirement for extravillous trophoblast entry into the proximal one-third of the myometrium. The One-Third Myometrium Enigma, introduced here, denotes the unresolved physiological rule that early placentation requires trophoblasts to traverse decidua and reach the proximal one-third of myometrium under hypoxia and nutrient scarcity. The hypothesis posits a timed rise in basal autophagy to sustain trophoblast energy homeostasis and invasion, accompanied by TFEB-driven lysosomal programs that enable villous cytotrophoblast syncytialization. Autophagic dysfunction could contribute to shallow invasion, chronic placental hypoxia, fetal growth restriction, and release of placental injury signals preceding maternal syndrome. Potential failure modes include reduced autophagic flux due to inhibition of autophagosome to lysosome fusion or mistimed persistence of hypoxia signaling, such as prolonged HIF-1α activity. Collectively, this evidence suggests that impaired autophagy is a testable contributor to preeclampsia pathogenesis. Predictions include early risk stratification with circulating autophagy markers and extracellular vesicle microRNAs, and therapeutic benefit from autophagy modulation that targets AMPK or mTOR or activates TFEB with safety constraints. This framework reframes preeclampsia as a disorder of placental quality control and specifies where and when autophagy may be required.

## Linked entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], TFEB (transcription factor EB) [NCBI Gene 7942]
- **Diseases:** preeclampsia (MONDO:0005081)

## Full-text entities

- **Genes:** TFEB (transcription factor EB) [NCBI Gene 7942] {aka ALPHATFEB, BHLHE35, TCFEB}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}
- **Diseases:** maternal syndrome (MESH:D000079262), placental injury (MESH:D010922), Autophagic Dysfunction (MESH:C536522), Preeclampsia (MESH:D011225), hypoxia (MESH:D000860), fetal growth restriction (MESH:D005317)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024584/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024584/full.md

## References

106 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024584/full.md

---
Source: https://tomesphere.com/paper/PMC13024584